BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11070166)

  • 21. Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner.
    Piepenbrink KH; Borbulevych OY; Sommese RF; Clemens J; Armstrong KM; Desmond C; Do P; Baker BM
    Biochem J; 2009 Oct; 423(3):353-61. PubMed ID: 19698083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
    J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.
    Gagnon SJ; Wang Z; Turner R; Damirjian M; Biddison WE
    J Immunol; 2003 Sep; 171(5):2233-41. PubMed ID: 12928367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope.
    Hoffmann TK; Loftus DJ; Nakano K; Maeurer MJ; Chikamatsu K; Appella E; Whiteside TL; DeLeo AB
    J Immunol; 2002 Feb; 168(3):1338-47. PubMed ID: 11801674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
    Collins EJ; Booth BL; Cerundolo V
    J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell receptor recognition via cooperative conformational plasticity.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Turner RV; Damirjian M; Wojnarowicz A; Biddison WE; Baker BM
    J Mol Biol; 2006 Oct; 363(1):228-43. PubMed ID: 16962135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility.
    Borbulevych OY; Piepenbrink KH; Gloor BE; Scott DR; Sommese RF; Cole DK; Sewell AK; Baker BM
    Immunity; 2009 Dec; 31(6):885-96. PubMed ID: 20064447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The basis for limited specificity and MHC restriction in a T cell receptor interface.
    Piepenbrink KH; Blevins SJ; Scott DR; Baker BM
    Nat Commun; 2013; 4():1948. PubMed ID: 23736024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501.
    Probst-Kepper M; Hecht HJ; Herrmann H; Janke V; Ocklenburg F; Klempnauer J; van den Eynde BJ; Weiss S
    J Immunol; 2004 Nov; 173(9):5610-6. PubMed ID: 15494511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes.
    Schaft N; Willemsen RA; de Vries J; Lankiewicz B; Essers BW; Gratama JW; Figdor CG; Bolhuis RL; Debets R; Adema GJ
    J Immunol; 2003 Feb; 170(4):2186-94. PubMed ID: 12574392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
    Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
    J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct molecular mechanisms account for the specificity of two different T-cell receptors.
    Anikeeva N; Lebedeva T; Krogsgaard M; Tetin SY; Martinez-Hackert E; Kalams SA; Davis MM; Sykulev Y
    Biochemistry; 2003 Apr; 42(16):4709-16. PubMed ID: 12705834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand.
    Davis-Harrison RL; Armstrong KM; Baker BM
    J Mol Biol; 2005 Feb; 346(2):533-50. PubMed ID: 15670602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
    Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
    Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supra-agonist peptides enhance the reactivation of memory CTL responses.
    Micheletti F; Canella A; Vertuani S; Marastoni M; Tosi L; Volinia S; Traniello S; Gavioli R
    J Immunol; 2000 Oct; 165(8):4264-71. PubMed ID: 11035060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis.
    Michielin O; Karplus M
    J Mol Biol; 2002 Nov; 324(3):547-69. PubMed ID: 12445788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.
    Höllsberg P; Weber WE; Dangond F; Batra V; Sette A; Hafler DA
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4036-40. PubMed ID: 7732026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.